Charles S. Berkman
Insider at Ligand Pharmaceuticals; Chief Legal Officer at OmniAb. Based in Emeryville, California.
- Rank
- 7219th of 14,644
- Companies held
- 2
- Largest holding
- LGND, 84.5% of total
- Latest SEC filing
- Apr 7, 2026
What the $13.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 38,191 split-adjusted | $286.94 | $11.0M | 84.5% | Form 4, Nov 1, 2022 |
| OmniAb OABI Common Stock | Directly | 399,085 | $5.03 | $2.0M | 15.5% | Form 4, Apr 7, 2026 |
Share counts are the amounts Charles S. Berkman reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7216 | William M. Boyd, III Chief Strategy Officer, Symbotic. Wilmington, MA | $13.0M |
| 7217 | Sanjeev K. Mehra Director, Avantor. Radnor, PA | $13.0M |
| 7218 | Christopher Nestor Cruz See Remarks, Shift4 Payments. Center Valley, PA | $13.0M |
| 7219 | Charles S. Berkman Insider, Ligand Pharmaceuticals. Emeryville, CA | $13.0M |
| 7220 | Elias A. Zerhouni, M.D Vice Chairman and President, OPKO Health. Washington, DC | $13.0M |
| 7221 | Michael J. Quillen Director, Martin Marietta Materials. Raleigh, NC | $13.0M |
| 7222 | Robert Golden Director, Hanover Bancorp. Mineola, NY | $13.0M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- John L. Higgins$120MDirector. #1162 overall
- Matthew W. Foehr$74.6MInsider. #1498 overall
- Todd C. Davis$57.2MChief Executive Officer. #1695 overall
- Jason Aryeh$31.7MDirector. #3493 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6393 overall
- Sunil Patel$13.3MInsider. #6658 overall
Questions
How much stock does Charles S. Berkman own?
Charles S. Berkman holds $12,966,059 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 7219th on the Stock Rich List.
Is this Charles S. Berkman's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Charles S. Berkman last buy or sell stock?
The most recent open-market trade on file is a sale of 7,157 OABI shares on Apr 7, 2026 at $1.49.